AbbVie (ABBV) Issues Inaugural Full-Year Outlook for 2013  
1/30/2013 9:47:03 AM

AbbVie today confirmed it delivered strong sales growth with its marketed pharmaceutical products in 2012. The proprietary pharmaceutical segment of Abbott, representing the majority of AbbVie's revenue, grew more than 8 percent globally on an operational basis, excluding a nearly 3 percent negative impact from foreign exchange.